Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
The main difference is that AHK-Cu is a synthetic copper peptide
Ongoing provider access is available for general questions and follow-up support
AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list
I would not trust anyone else with my face
Metabolic disorder research is another big opportunity
US$ 24.07
US$ 28.88
US$ 21.06
US$ 27.48
US$ 28.02